Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Value · Gmo

GMO U.S. Value ETF (GMOV)

Ticker GMOV · Since 2024-10-28 · · Holdings as of May 31, 2026

Expense ratio
0.5%$50/yr per $10k
1-yr return
+14.8%as of Dec 2025
Net assets
$90.9Mall share classes
Holdings
165

Bottom line

Is GMOV a good fund? The bottom line

GMOV is a managed large value ETF from Gmo.

Its expense ratio is 0.5% — about $50 a year on every $10,000 invested, cheaper than 81% of large value funds we track.

It returned +14.8% over one year (as of Dec 31, 2025, per its prospectus).

With $90.9 million in net assets and 165 holdings, its largest position is Meta Platforms Inc (5.2%) and the top 10 make up 28.4% of the portfolio.

What stands out

  • Low cost: cheaper than 81% of large value peers

Updated Nov 19, 2026

What GMOV invests in

Total return.

"The Fund is an actively managed ETF that seeks to achieve its investment objective by investing the Funds assets primarily in securities traded in U.S. equity markets. GMO selects the securities the Fund buys and sells based on its evaluation of companies published financial information, securities prices, equity and other markets, the overall global economy, and governmental policies. The Fund seeks to capitalize opportunistically on what GMO believes to be market dislocations within the U.S. equity markets. In selecting securities for the Fund, GMO uses a combination of proprietary quantitative investment methods to identify U.S. equities GMO believes have positive return potential relative to other U.S. equities. A key component of the process is GMOs proprietary methodology for assessing values of company tangible and intangible assets and generating equity return forecasts, which…

From the fund's prospectus (filed Jun 30, 2026).

GMOV performance

Fund calendar-year total returns, 2025–2025 2025: +14.8% +14.8% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
GMOV+14.8%——
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full GMOV performance history →

What GMOV costs

On a $10,000 investment, GMOV's 0.5% expense ratio costs about $50 a year. The prospectus estimates $628 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full GMOV fee table →

GMOV top 10 holdings

#Holding% of fund
1Meta Platforms Inc5.18%
2Alphabet Inc3.89%
3QUALCOMM Inc3.36%
4Merck & Co Inc2.73%
5Exxon Mobil Corp2.58%
6Verizon Communications Inc2.37%
7Bank of America Corp2.19%
8Pfizer Inc2.10%
9UnitedHealth Group Inc2.02%
10Johnson & Johnson1.98%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 28.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to GMOV

More funds like GMOV →

GMOV FAQ

What is the expense ratio of GMOV?
GMOV's expense ratio is 0.5%, which works out to about $50 a year for every $10,000 invested. The prospectus estimates total costs of $628 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is GMOV a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 81% of large value peers. This is general information, not personalized advice.
What does GMOV hold?
GMOV's largest holdings are Meta Platforms Inc (5.2%), Alphabet Inc (3.9%), QUALCOMM Inc (3.4%), Merck & Co Inc (2.7%), Exxon Mobil Corp (2.6%). It holds 165 positions in total as of May 31, 2026 (SEC Form N-PORT).
Who manages GMOV?
GMOV is offered by Gmo through GMO ETF Trust.